With regard to the article within the September 2024 difficulty entitled ‘‘Investigation of lactotransferrin messenger RNA expression ranges as an anti–kind 2 bronchial asthma biomarker’’ (J Allergy Clin Immunol 2024;154:609-18), the authors have submitted a treatment funding assertion, because the funding particulars had been lacking within the unique assertion. Based on the Extreme Bronchial asthma Analysis Program (SARP) coverage, manuscripts utilizing SARP knowledge ought to undergo manuscript proposal and evaluation steps. As a result of misunderstanding of the senior writer, these steps had been missed throughout publication.
Trending Merchandise
Added to wishlistRemoved from wishlist 0
$25.00
Added to wishlistRemoved from wishlist 0
$29.71
Added to wishlistRemoved from wishlist 0
$32.99
Added to wishlistRemoved from wishlist 0
$13.99
Added to wishlistRemoved from wishlist 0
$17.99
Added to wishlistRemoved from wishlist 0
$7.85
Added to wishlistRemoved from wishlist 0
$8.83
Added to wishlistRemoved from wishlist 0
$45.40
Added to wishlistRemoved from wishlist 0
$9.99
Carlyle Cat’s Claw Capsules 1000mg | 180 Count | Uncaria Tomentosa | Non-GMO, Gluten Free Supplement
Added to wishlistRemoved from wishlist 0
$15.28